AgomAb Therapeutics NV · NASDAQ:AGMB
AgomAb Therapeutics NV shareholders
As of Sep 30, 2026, 38 institutions reported holding AgomAb Therapeutics NV, 57.0% of its shares. Largest: EQT Fund Management S.a r.l., Sanofi and Cormorant Asset Management, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of AgomAb Therapeutics NV | Change | Filed |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.14M | 10.4% | new | Nov 12, 2026 |
| Sanofi | 2.78M | 5.7% | new | Nov 5, 2026 |
| Cormorant Asset Management, LP | 2.47M | 5.0% | new | Nov 16, 2026 |
| Pfizer Inc | 2.15M | 4.4% | new | Nov 12, 2026 |
| TCG Crossover Management, LLC | 1.82M | 3.7% | new | Nov 16, 2026 |
| Nantahala Capital Management, LLC | 1.75M | 3.5% | new | Nov 13, 2026 |
| Redmile Group, LLC | 1.74M | 3.5% | new | Nov 16, 2026 |
| Federated Hermes, Inc. | 1.61M | 3.3% | new | Nov 12, 2026 |
| Casdin Capital, LLC | 1.55M | 3.1% | new | Nov 16, 2026 |
| Andera Partners | 1.54M | 3.1% | new | Oct 16, 2026 |